isomethyleugenol has been researched along with Down Syndrome in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jankun, J; Matthews-Brzozowska, T; Matthews-Kozanecka, M; Skrzypczak-Jankun, E; Wyganowska-Świątkowska, M | 1 |
Antonarakis, SE; Bonilla, X; Borel, C; Chevalier, C; Deutsch, S; Falconnet, E; Farinelli, L; Feki, A; Gagnebin, M; Garieri, M; Gehrig, C; Gonzalez, D; Guigo, R; Guipponi, M; Herault, Y; Hibaoui, Y; Kind, J; Letourneau, A; Migliavacca, E; Popadin, K; Robyr, D; Sailani, MR; Sandstrom, RS; Santoni, FA; Stamatoyannopoulos, JA; Thurman, R; van Steensel, B; Vannier, A | 1 |
de Jonge, R; Helbing, WA; Ottenkamp, J; Steegers, EA; Steegers-Theunissen, RP; van Driel, LM; van Zelst, BD | 1 |
Barbosa-Morais, NL; Conboy, CM; Fisher, EM; Odom, DT; Schmidt, D; Tavaré, S; Tybulewicz, VL; Vanes, L; Wilson, MD | 1 |
de Jonge, R; Helbing, WA; Obermann-Borst, SA; Steegers, EA; Steegers-Theunissen, RP; van Driel, LM; Wildhagen, MF | 1 |
Andria, G; Castegna, A; Iacobazzi, F; Iacobazzi, V; Infantino, V; Scala, I; Spera, I | 1 |
Geisel, J; Gortner, L; Hartmuth, K; Herrmann, W; Nijhout, HF; Obeid, R; Reed, MC; Rohrer, TR | 1 |
Duncan, TM; Nijhout, HF; Reed, MC | 1 |
Kumar, A; Mehta, S; Pandey, LK; Rai, AK; Raman, R; Singh, S | 1 |
Andria, G; D'Angelo, S; D'Aniello, A; De Bonis, ML; Galletti, P; Ingrosso, D; Raimo, M; Scala, I; Sorrentino, A; Zappia, V | 1 |
Hara, J; Inoue, M; Ishihara, S; Kawa-Ha, K; Kurahashi, H; Murayama, N; Okada, S; Tawa, A; Yumura-Yagi, K | 1 |
Candide, C; de Blois, MC; Lejeune, J; Mazière, C; Mazière, JC; Polonovski, J | 1 |
1 review(s) available for isomethyleugenol and Down Syndrome
Article | Year |
---|---|
Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?
Topics: Animals; Biomarkers; Catechin; Down Syndrome; Humans; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Methylation; Proteolysis; Signal Transduction; Tissue Plasminogen Activator | 2018 |
11 other study(ies) available for isomethyleugenol and Down Syndrome
Article | Year |
---|---|
Domains of genome-wide gene expression dysregulation in Down's syndrome.
Topics: Animals; Cells, Cultured; Chromatin; Chromosomes, Human, Pair 21; Chromosomes, Mammalian; DNA Replication Timing; Down Syndrome; Female; Fetus; Fibroblasts; Gene Expression Regulation; Genome; Histones; Humans; Induced Pluripotent Stem Cells; Lysine; Male; Methylation; Mice; Transcriptome; Twins, Monozygotic | 2014 |
Maternal global methylation status and risk of congenital heart diseases.
Topics: Adult; Biomarkers; Case-Control Studies; Child; Down Syndrome; Female; Heart; Heart Defects, Congenital; Humans; Hyperhomocysteinemia; Infant; Linear Models; Methylation; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine | 2008 |
Species-specific transcription in mice carrying human chromosome 21.
Topics: Animals; Base Sequence; Cell Nucleus; Chromatin Assembly and Disassembly; Chromatin Immunoprecipitation; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Gene Expression Regulation; Hepatocyte Nuclear Factors; Hepatocytes; Histones; Humans; Methylation; Mice; Oligonucleotide Array Sequence Analysis; Regulatory Sequences, Nucleic Acid; Species Specificity; Transcription Initiation Site; Transcription, Genetic | 2008 |
Congenital heart defects and biomarkers of methylation in children: a case-control study.
Topics: Biomarkers; Case-Control Studies; Child, Preschool; Down Syndrome; Female; Folic Acid; Heart Defects, Congenital; Humans; Hyperhomocysteinemia; Infant; Male; Methylation; Netherlands; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Vitamin B 12 | 2011 |
Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome.
Topics: Adolescent; Carrier Proteins; Cell Line, Transformed; Child; Child, Preschool; Cytosol; Down Syndrome; Glutathione; Humans; Infant; Methylation; Mitochondria; S-Adenosylmethionine | 2011 |
Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model.
Topics: Adolescent; Adult; Betaine; Biomarkers; Case-Control Studies; Child; Child, Preschool; Choline; Cystathionine; Cysteine; Down Syndrome; Female; Glutathione; Humans; Infant; Male; Methionine; Methylation; Models, Theoretical; S-Adenosylhomocysteine; S-Adenosylmethionine; Sarcosine; Young Adult | 2012 |
The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model.
Topics: Cystathionine beta-Synthase; Down Syndrome; Folic Acid; Folic Acid Deficiency; Half-Life; Homocysteine; Humans; Methionine; Methylation; Models, Theoretical; Nutrition Surveys; Nutritional Status; Oxidative Stress; S-Adenosylmethionine; Vitamin B 12 Deficiency; Vitamin B Complex; Vitamins | 2013 |
MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adolescent; Adult; Alleles; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Down Syndrome; Female; Folic Acid; Gene Frequency; Homozygote; Humans; India; Male; Maternal Age; Methylation; Middle Aged; Nondisjunction, Genetic; Odds Ratio; Pedigree; Polymorphism, Single Nucleotide; Pregnancy; Risk Factors | 2006 |
Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome.
Topics: Case-Control Studies; Child; Down Syndrome; Erythrocyte Aging; Erythrocyte Membrane; Herpesvirus 4, Human; Humans; Isoaspartic Acid; Lymphocytes; Membrane Proteins; Methemoglobin; Methionine; Methylation; Oxidative Stress; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Recombinant Proteins; S-Adenosylhomocysteine | 2007 |
Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
Topics: Bone Marrow; Cell Differentiation; DNA; Down Syndrome; Female; Genes; Heterozygote; Humans; Hypoxanthine Phosphoribosyltransferase; Infant, Newborn; Infant, Newborn, Diseases; Male; Methylation; Myeloproliferative Disorders; Phosphoglycerate Kinase; Polymorphism, Restriction Fragment Length; Stem Cells; X Chromosome | 1991 |
[Phospholipid methylation in fibroblasts of patients with trisomy 21].
Topics: Cells, Cultured; Down Syndrome; Fibroblasts; Humans; Methylation; Phospholipids; Skin | 1987 |